Erin Mulvihill is an Assistant Professor at the University of Ottawa in the Department of Biochemistry, Microbiology and Immunology and is a Scientist at the University of Ottawa Heart Institute. She completed her Ph.D. in Biochemistry at the University of Western
Ontario with Dr. Murray Huff and her post-doctoral training at Lunenfeld Tanenbaum Research Institute at Mount Sinai Hospital with Dr. Daniel Drucker. Dr. Mulvihill established her independent research program in July 2017, and a major focus of her lab is to elucidate
how diabetes contributes to an increased risk of cardiovascular disease. Dr. Mulvihill has been awarded the Diabetes Canada New Investigator Award and a CIHR New Investigator award. Her research program is supported by grants from NSERC, CIHR and CFI.
- To understand the role of dipeptidyl peptidase 4 action on the incretin hormones and its significance in type 2 diabetes
- To examine the expanding role of dipeptidyl peptidase in liver and cardiovascular disease